Franck B, Rowold A, Wegner C, Eckert H G
Philos Trans R Soc Lond B Biol Sci. 1976 Feb 5;273(924):181-9. doi: 10.1098/rstb.1976.0008.
Insights into details of the biomechanism by which porphobilinogen (1) cyclotetramerizes to uroporphyrinogen III (2) as well as promising synthetic applications are provided by investigation of this reaction in vitro. The cyclotetramerization of newly prepared norporphobilinogen (5) proved to be extemely specific due to strong conformation control. Advantage was taken of this finding by preparing a N,N,N,N-tetramethyl-porphyrinogen (13a) for the first time. Protected derivatives of the linear tetramer of porphobilinogen (20c) which is regarded as an intermediate of the cyclotetramerization were gained by total synthesis and their transformations investigated.
通过对该反应进行体外研究,深入了解了胆色素原(1)环四聚化生成尿卟啉原III(2)的生物力学细节以及有前景的合成应用。新制备的去甲胆色素原(5)的环四聚化由于强大的构象控制而被证明具有极高的特异性。首次制备N,N,N,N-四甲基卟啉原(13a)利用了这一发现。通过全合成获得了被视为环四聚化中间体的胆色素原线性四聚体的保护衍生物(20c),并对其转化进行了研究。